Cyclacel Pharmaceuticals Statistics
Total Valuation
CYCC has a market cap or net worth of $2.11 million. The enterprise value is -$1.23 million.
| Market Cap | 2.11M |
| Enterprise Value | -1.23M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CYCC has 1.32 million shares outstanding. The number of shares has increased by 12.32% in one year.
| Shares Outstanding | 1.32M |
| Shares Change (YoY) | +12.32% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.12% |
| Owned by Institutions (%) | 16.73% |
| Float | 1.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.02 |
| Forward PS | n/a |
| PB Ratio | 3.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.06.
| Current Ratio | 0.91 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -450.90% and return on invested capital (ROIC) is -3,952.33%.
| Return on Equity (ROE) | -450.90% |
| Return on Assets (ROA) | -152.20% |
| Return on Capital (ROIC) | -3,952.33% |
| Revenue Per Employee | $35,000 |
| Profits Per Employee | -$1.90M |
| Employee Count | 12 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.59% in the last 52 weeks. The beta is 0.57, so CYCC's price volatility has been lower than the market average.
| Beta (1Y) | 0.57 |
| 52-Week Price Change | -81.59% |
| 50-Day Moving Average | 2.29 |
| 200-Day Moving Average | 4.85 |
| Relative Strength Index (RSI) | 42.04 |
| Average Volume (30 Days) | 51,998 |
Short Selling Information
The latest short interest is 38,411, so 2.91% of the outstanding shares have been sold short.
| Short Interest | 38,411 |
| Short Previous Month | 24,336 |
| Short % of Shares Out | 2.91% |
| Short % of Float | 3.33% |
| Short Ratio (days to cover) | 1.21 |
Income Statement
In the last 12 months, CYCC had revenue of $420,000 and -$22.76 million in losses. Loss per share was -$26.75.
| Revenue | 420,000 |
| Gross Profit | 420,000 |
| Operating Income | -25.45M |
| Pretax Income | -25.55M |
| Net Income | -22.76M |
| EBITDA | -25.52M |
| EBIT | -25.55M |
| Loss Per Share | -$26.75 |
Balance Sheet
The company has $3.38 million in cash and $37,000 in debt, giving a net cash position of $3.34 million or $2.53 per share.
| Cash & Cash Equivalents | 3.38M |
| Total Debt | 37,000 |
| Net Cash | 3.34M |
| Net Cash Per Share | $2.53 |
| Equity / Book Value | 607,000 |
| Book Value Per Share | 0.46 |
| Working Capital | -717,000 |
Cash Flow
In the last 12 months, operating cash flow was -$16.11 million and capital expenditures -$6,000, giving a free cash flow of -$16.12 million.
| Operating Cash Flow | -16.11M |
| Capital Expenditures | -6,000 |
| Free Cash Flow | -16.12M |
| FCF Per Share | -$19.12 |
Margins
Gross margin is 100.00%, with operating and profit margins of -6,060.24% and -5,418.10%.
| Gross Margin | 100.00% |
| Operating Margin | -6,060.24% |
| Pretax Margin | -6,083.57% |
| Profit Margin | -5,418.10% |
| EBITDA Margin | -6,076.19% |
| EBIT Margin | -6,083.57% |
| FCF Margin | -3,837.62% |
Dividends & Yields
CYCC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -12.32% |
| Shareholder Yield | -12.32% |
| Earnings Yield | -1,078.88% |
| FCF Yield | -764.17% |
Analyst Forecast
The average price target for CYCC is $70.50, which is 4,306.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $70.50 |
| Price Target Difference | 4,306.25% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 245.99% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 18, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Dec 18, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
CYCC has an Altman Z-Score of -77.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -77.57 |
| Piotroski F-Score | 2 |